This filing is a procedural submission of an earnings transcript. As no new data is provided, there is no immediate actionable signal. Monitor the transcript content for any guidance changes or material updates that could affect the stock.
RDY drugs
RDY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 18 $13.60entry
- T+1 · 6mo ago −1.10%α −0.45% · $13.45
- T+5 · 6mo ago +1.10%α −0.52% · $13.75
- T+20 · 5mo ago −2.21%α −3.79% · $13.30
- T+60 · 3mo ago −8.90%α −13.75% · $12.39
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Dr. Reddy's submitted a 6-K filing enclosing the transcript of its Q4 FY2026 earnings call held on May 12, 2026. The filing itself contains no new financial data or material disclosures, it is a routine procedural submission of the call transcript. Traders should review the transcript for any material updates, but this filing alone has no immediate stock impact.
Key Facts
- Form 6-K filed on May 18, 2026, covering the period ended May 18, 2026.
- Exhibit 99.1 is a letter to stock exchanges enclosing the earnings call transcript for Q4 FY2026.
- No financial figures or material business updates are provided in the filing itself.
- The transcript is available via a weblink included in the exhibit.
Financial Impact
No financial data disclosed in this filing.
Risk Factors
- The transcript may contain adverse or unexpected commentary not reflected in this filing.
- Absence of financial details in the filing itself limits visibility into results.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000341 |
| Document: 0001575872-26-000341-index.html | 0001575872-26-000341 |
| Document: 0001575872-26-000341.txt | 0001575872-26-000341 |
Track record
73 reports on RDY
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
- Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
- Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
- Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
- Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers